Seedrs • Ponda
Financement participatif (equity crowdfunding)
Ponda
Ponda is a biomaterials company developing next-generation textiles from wetland plants.
Key project data
Target amount
1,4 MEUR
Équité
15.73%
Valuations
7,5 MEUR
Would AI invest?
62/100
1
100
Aperçu généré par l'IA
AI project overview
Condensed summary based on project data
<p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong>Ponda (SALTYCO LTD) — Crowdfunding Investor Memo</strong></span></span></p> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><em>Plant-based insulation (BioPuff) made from wetland-grown bulrush, tied to peatland regeneration.</em></span></span></p> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong>Sector: </strong>Biomaterials / textile insulation<strong> · Stage: </strong>Seed (crowdfunding top-up)<strong> · HQ: </strong>Bristol, United Kingdom<strong> · Raise: </strong>£1,400,003 target (Republic Europe)</span></span></p> <table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:6.5in"> <tbody> <tr> <td style="background-color:#faeeda; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:173px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">AI SCORE</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:451px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong>Why this score:</strong></span></span></p> </td> </tr> <tr> <td style="background-color:#faeeda; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:173px"> <p> </p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:451px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">strong, well-corroborated team and traction — Imperial/RCA founders, brand use by Berghaus, Stella McCartney and Ahluwalia, and 12 tonnes of material harvested in 2025.</span></span></li> </ul> </td> </tr> <tr> <td style="background-color:#faeeda; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:173px"> <p style="text-align:center"><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="font-size:28.0pt"><span style="color:black">62 / 100</span></span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:451px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Product performance is validated in the deck (BioPuff Wadding CLO 1.41 vs PrimaLoft Gold 0.92) but IP is only patent-pending with thin detail.</span></span></li> </ul> </td> </tr> <tr> <td style="background-color:#faeeda; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:173px"> <p style="text-align:center"><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">⭐ Moderate</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:451px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Financials are early — FY2025 turnover c.£21k against deep operating losses; this is a market-creation bet, not a revenue story.</span></span></li> </ul> </td> </tr> <tr> <td style="background-color:#faeeda; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:173px"> <p style="text-align:center"> </p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:451px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Deal terms are the weakest element: no disclosed valuation or ownership %, an adverse surplus split for Series Seed on the upside, and an illiquid nominee-held stake.</span></span></li> </ul> </td> </tr> <tr> <td style="background-color:#faeeda; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:173px"> <p style="text-align:center"> </p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:451px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Market opportunity is large but sizing is thin and adoption in textiles is historically slow.</span></span></li> </ul> </td> </tr> </tbody> </table> <p> </p> <table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:6.5in"> <tbody> <tr> <td style="background-color:#e6f1fb; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:624px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">ℹ️ This is not investment advice.</span></strong><span style="color:black"> The purpose of this overview is to help potential investors preselect crowdfunding projects quickly without making a final investment decision. Before investing, the final selected project should be reviewed in detail based on the information provided by the company on the respective crowdfunding platform. AI can make mistakes, so you need to double-check data.</span></span></span></p> </td> </tr> </tbody> </table> <h1><span style="font-size:16pt"><span style="font-family:"Times New Roman",serif"><span style="color:#2e74b5">🎯 Key goal</span></span></span></h1> <table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:6.5in"> <thead> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:156px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Target return</span></strong></span></span></p> </td> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:156px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Time horizon</span></strong></span></span></p> </td> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:156px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Target basis</span></strong></span></span></p> </td> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:156px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">AI view on reaching this goal</span></strong></span></span></p> </td> </tr> </thead> <tbody> <tr> <td style="border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:156px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong>🎯 ~10x</strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:156px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong>⏱ 5–7 yrs</strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:156px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong>Default</strong> — the company disclosed no target return or exit horizon, so the standard early-stage target applies.</span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:156px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Plausible but unproven — the technology and brand interest are real, but negligible revenue and undisclosed deal economics make the path to a 10x exit highly uncertain.</span></span></p> </td> </tr> </tbody> </table> <p> </p> <table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:6.5in"> <tbody> <tr> <td style="background-color:#fbf1dc; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:624px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">⚠️ Why aim for ~10x?</span></strong><span style="color:black"> Startup investing is high risk. Most early-stage companies fail or return little. A small number of winners must compensate for the losers, so each individual investment is typically targeted at roughly 10x over 5–7 years. A lower target across a portfolio of risky bets usually does not produce a positive overall return. This is why the we apply a 10x / 5–7 year target when the company does not specify its own.</span></span></span></p> </td> </tr> </tbody> </table> <h1><span style="font-size:16pt"><span style="font-family:"Times New Roman",serif"><span style="color:#2e74b5"><span style="font-family:"Segoe UI Emoji",sans-serif">🏢</span> Company description</span></span></span></h1> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Ponda (legal entity SALTYCO LTD, formerly "Saltyco") is a Bristol-based biomaterials company founded in 2020 by a team from the Imperial College London / Royal College of Art Innovation Design Engineering double Master's, led by CEO Julian Ellis-Brown with co-founders Finlay Duncan (CTO), Neloufar Taheri (COO) and Antonia Jara-Contreras (CCO). Its flagship product, BioPuff, is a plant-based insulation made from Typha (bulrush) grown on rewetted lowland peat through paludiculture — farming on rewetted wetlands — with the wadding blended from Typha fibre and recycled polyester (the label states 80% Typha / 20% RPET). The company reports thermal performance matching goose down at lower cost, and its deck cites a CLO value of 1.41 for 100gsm wadding versus 0.92 for PrimaLoft Gold. Ponda has provided material or prototypes to Berghaus, Stella McCartney (Falabella bag, AW24), Ahluwalia (AW26) and Sheep Inc., and reports harvesting 12 tonnes of material in 2025. It uses a multi-product model — selling wadding, BioPuff garments, B2B merchandise and D2C — to offset differing sales-cycle durations, and ties each garment to a wetland-regeneration impact claim. This round (a £1,400,003 target on Republic Europe) is stated to fund manufacturing scale-up (40%), go-to-market and eco-merchandise (25%), a large-scale demonstrator (20%) and R&D (15%), following a seed round in late 2025 co-led by Faber and Counteract.</span></span></p> <h1><span style="font-size:16pt"><span style="font-family:"Times New Roman",serif"><span style="color:#2e74b5">📈 Path to target return</span></span></span></h1> <table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:6.5in"> <tbody> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:173px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Sector heuristic</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:451px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">For an early-stage deeptech/biomaterials company raising direct equity, a ~10x return over 5–7 years typically requires reaching commercial-scale production and multi-million revenue, then a trade sale to a larger materials or apparel group (or licensing) at a mid-to-high revenue multiple. Capital is committed until such an exit; no dividends are expected.</span></span></p> </td> </tr> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:173px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Current key metric</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:451px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">FY2025 turnover c.£21k; 12 tonnes of material harvested in 2025 (up from 3.5 tonnes in 2022); pilot/multi-tonne facility in Bristol. Pre-commercial.</span></span></p> </td> </tr> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:173px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Required scale at exit</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:451px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">The company's own SOM target is £25M (3% of a £800M SAM) by 2030. Reaching a 10x-supporting exit implies converting current pilot output and brand pilots into repeatable commercial supply at a large multiple of today's negligible revenue.</span></span></p> </td> </tr> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:173px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Implied IRR</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:451px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">A 10x return over 5–7 years implies roughly a 39%–58% annualised IRR (10^(1/7)≈1.39; 10^(1/5)≈1.58). This is the standard hurdle the default target embeds; it is not a company projection.</span></span></p> </td> </tr> </tbody> </table> <h1><span style="font-size:16pt"><span style="font-family:"Times New Roman",serif"><span style="color:#2e74b5">💶 Valuation</span></span></span></h1> <table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:6.5in"> <tbody> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:173px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Pre-money valuation</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:451px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Not disclosed in provided materials — investor cannot assess this before investing.</span></span></p> </td> </tr> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:173px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Post-money valuation</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:451px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Not disclosed in provided materials.</span></span></p> </td> </tr> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:173px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Instrument</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:451px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Equity — new "Series Seed" shares (111,643 offered at £12.54 each; £0.00001 nominal value).</span></span></p> </td> </tr> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:173px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Ownership % offered</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:451px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Not disclosed. The round is defined only by share count × price (111,643 × £12.54 = £1,400,003); without the pre-round share count, ownership % cannot be computed.</span></span></p> </td> </tr> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:173px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">How the valuation was set</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:451px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Methodology not disclosed in provided materials.</span></span></p> </td> </tr> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:173px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">External benchmarks</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:451px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">A late-2025 seed round was reported at $2.4M / c.€2.09M (co-led Faber + Counteract), with Republic's own pre-registration page citing a "recent £1.8m VC seed"; total funding to date c.€5.6M / $6.6M including grants. No pre-money figure was published for that round.</span></span></p> </td> </tr> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:173px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Notable terms</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:451px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Series Seed carries a liquidation preference (£12.54 or £10.03 per share plus arrears); shares are held via a nominee (Seedrs Nominees Limited); drag-along applies above 50% and tag-along on change of control.</span></span></p> </td> </tr> </tbody> </table> <h1><span style="font-size:16pt"><span style="font-family:"Times New Roman",serif"><span style="color:#2e74b5">📜 Instrument & investor terms</span></span></span></h1> <h2><span style="font-size:13pt"><span style="font-family:"Times New Roman",serif"><span style="color:#2e74b5">What you own</span></span></span></h2> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">You would own equity in the form of new "Series Seed" shares in SALTYCO LTD. You do not hold these shares directly: legal title is held on your behalf by a nominee, Seedrs Nominees Limited, and your rights are administered by the platform (Republic Europe); no separate SPV is used. The shares carry pro rata voting rights, but because they are pooled and voted through the nominee, an individual retail investor's practical influence over company decisions is minimal. Exit decisions are effectively made by the larger shareholders: a sale can be forced when more than 50% of shareholders agree (see drag-along below), which can include you whether or not you personally consent.</span></span></p> <h2><span style="font-size:13pt"><span style="font-family:"Times New Roman",serif"><span style="color:#2e74b5">Dilution and future rounds</span></span></span></h2> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">The company expects to raise further capital — the deck describes funding go-to-market in 2026 and runway to November 2027, and the platform materials state explicitly that future funding rounds may dilute shareholdings and reduce returns. No anti-dilution protection and no pre-emption rights are disclosed for crowdfund investors, so you should assume you have neither. "Dilution" means your percentage of the company falls when new shares are issued to new investors.</span></span></p> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><em>Worked example (illustrative — the company did not disclose a valuation, so these figures are hypothetical and used only to show the mechanics). </em>Suppose, purely for illustration, the post-money value of this round were £8M. A £1,000 investment would then buy roughly 0.0125% of the company. If Ponda later raised £4M at a £12M pre-money valuation (a successful "up-round" Series A), your stake would dilute to about 0.0094%, and the implied value of your £1,000 would rise to roughly £1,500. If instead the next round were a "down-round" at a £4M pre-money valuation raising £2M, your stake would dilute to about 0.0083% and the implied value of your £1,000 would fall to roughly £500 — a drop of about 50%. The direction is what matters: without anti-dilution protection, a lower-priced future round hurts you more than the founders.</span></span></p> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">No ESOP (employee option pool) size or expansion plan is disclosed, so its dilutive effect cannot be assessed. Because no pre-emption rights are disclosed, you should assume you cannot automatically invest again in future rounds to defend your percentage.</span></span></p> <h2><span style="font-size:13pt"><span style="font-family:"Times New Roman",serif"><span style="color:#2e74b5">Exit and liquidation mechanics</span></span></span></h2> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">On a sale, return of capital or wind-down, creditors (secured, unsecured, employees, bondholders and tax authorities) are paid first — before any shareholder. Among shareholders, Series Seed holders (this round) then first receive their "Preference Amount" of £12.54 or £10.03 per share plus any arrears, while Ordinary, B Ordinary and Pro Rata Series Seed holders receive only a token 0.00001% of that amount. Crucially, the remaining surplus is then split 99.99999% to Ordinary / B Ordinary / Pro Rata Series Seed and only 0.00001% to Series Seed — so on a high-value exit your upside as a Series Seed holder is effectively capped near your preference amount plus arrears, and the bulk of the gains flow to other classes. This is an unusual and, on the upside, adverse structure that is worth confirming against the company's Articles before investing.</span></span></p> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">"Drag-along" means that if more than 50% of shareholders vote to sell the company, the rest — including you — can be forced to sell on the same terms. "Tag-along" works in your favour: on a change of control you have the right to join a sale on the same terms as the selling shareholders, so you are not left behind in a deal negotiated by others.</span></span></p> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">No fixed lock-up period is disclosed, but transfers are restricted by the Articles and shareholders' agreement, and the platform states there may be no secondary market — and even if one exists, no sale at an acceptable price is guaranteed. You should treat this investment as illiquid and assume your capital is committed for multiple years (typically 5–7 for early-stage equity), with a real possibility of never being able to sell.</span></span></p> <h2><span style="font-size:13pt"><span style="font-family:"Times New Roman",serif"><span style="color:#2e74b5">Key risks specific to this instrument</span></span></span></h2> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Capped upside for your share class — the surplus split sends 99.99999% to Ordinary/B Ordinary/Pro Rata Series Seed and only 0.00001% to Series Seed, so on a strong exit you may receive little more than your preference amount plus arrears.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">No disclosed valuation or ownership % — you cannot know what fraction of the company £1 buys, or judge whether the £12.54 share price is fair, before investing.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">No anti-dilution or pre-emption rights for crowdfund investors — a future down-round dilutes you disproportionately and you cannot automatically top up to defend your stake.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Drag-along at just above 50% — larger shareholders can force a sale (and its terms) on you without your consent.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Nominee-held, illiquid stake — you hold shares via Seedrs Nominees Limited with no assured secondary market, so your rights depend on the nominee/platform continuing to operate.</span></span></li> </ul> <h2><span style="font-size:13pt"><span style="font-family:"Times New Roman",serif"><span style="color:#2e74b5">Items not disclosed</span></span></span></h2> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">The following were not disclosed in the provided materials. Absence of disclosure means you cannot assess these before investing:</span></span></p> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Pre-money and post-money valuation, and the valuation methodology.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">The full, current cap table and pre-round share count (a before/after document is referenced but was not provided).</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">ESOP / employee option pool size and any planned expansion.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Anti-dilution provisions for any class of shareholder.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Pre-emption rights for crowdfund investors.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Founder vesting schedule and leaver provisions.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Investor information rights — the frequency and type of reporting you would receive.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Any fixed lock-up period.</span></span></li> </ul> <h1><span style="font-size:16pt"><span style="font-family:"Times New Roman",serif"><span style="color:#2e74b5">📊 Score breakdown</span></span></span></h1> <table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:6.5in"> <thead> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:167px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Category</span></strong></span></span></p> </td> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:73px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Score</span></strong></span></span></p> </td> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:73px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Weight</span></strong></span></span></p> </td> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:311px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Verdict & key reason</span></strong></span></span></p> </td> </tr> </thead> <tbody> <tr> <td style="border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:167px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong>Team & execution</strong></span></span></p> </td> <td style="background-color:#faeeda; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:73px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">78</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:73px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">22%</span></span></p> </td> <td style="background-color:#faeeda; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:311px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Moderate-strong</span></strong><span style="color:black"> — Imperial/RCA founders, credible advisors and recognition (Forbes 30U30, Global Change Award); execution risk across tech, supply chain and market creation is explicitly flagged.</span></span></span></p> </td> </tr> <tr> <td style="border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:167px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong>Product & technology (IP)</strong></span></span></p> </td> <td style="background-color:#faeeda; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:73px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">68</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:73px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">22%</span></span></p> </td> <td style="background-color:#faeeda; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:311px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Moderate</span></strong><span style="color:black"> — Validated thermal performance vs PrimaLoft in the deck, but IP is only patent-pending with no granted-patent detail.</span></span></span></p> </td> </tr> <tr> <td style="border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:167px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong>Traction & commercial validation</strong></span></span></p> </td> <td style="background-color:#faeeda; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:73px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">66</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:73px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">20%</span></span></p> </td> <td style="background-color:#faeeda; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:311px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Moderate</span></strong><span style="color:black"> — Real, independently corroborated brand use and rising tonnage, offset by negligible revenue (c.£21k FY2025).</span></span></span></p> </td> </tr> <tr> <td style="border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:167px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong>Market & competition</strong></span></span></p> </td> <td style="background-color:#faece7; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:73px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">55</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:73px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">13%</span></span></p> </td> <td style="background-color:#faece7; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:311px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Caution</span></strong><span style="color:black"> — Large stated TAM (£10B) but thin sizing and historically slow textile adoption against entrenched down and synthetic incumbents.</span></span></span></p> </td> </tr> <tr> <td style="border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:167px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong>Financials & runway</strong></span></span></p> </td> <td style="background-color:#faece7; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:73px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">42</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:73px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">11%</span></span></p> </td> <td style="background-color:#faece7; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:311px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Caution</span></strong><span style="color:black"> — Deep operating losses and near-zero revenue, partially offset by a funded runway to November 2027.</span></span></span></p> </td> </tr> <tr> <td style="border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:167px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong>Deal terms & investor protection</strong></span></span></p> </td> <td style="background-color:#fcebeb; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:73px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">38</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:73px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">12%</span></span></p> </td> <td style="background-color:#fcebeb; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:311px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Weak</span></strong><span style="color:black"> — No disclosed valuation, an adverse Series Seed surplus split, nominee custody and illiquidity weigh heavily against the retail investor.</span></span></span></p> </td> </tr> </tbody> </table> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong>Why these weights? </strong>This is an early-stage deeptech/biomaterials company, so Team (22%) and Product & technology (22%) carry the most weight — at this stage, execution capability and whether the material genuinely works are the biggest value drivers, and the deeptech nature justifies lifting technology weight above the standard seed default. Traction (20%) is weighted highly because real brand use is the strongest external signal here. Market (13%) is held down both because the dossier's sizing is thin (LIMITED data quality) and because it is less decisive than execution at this stage. Financials (11%) reflects a pre-revenue company where the numbers are expected to be small. Deal terms & investor protection (12%) is weighted meaningfully because, for a non-professional investor, the undisclosed valuation and adverse exit economics directly affect what they receive. All six categories were evaluable, so no N/A redistribution was needed; weights sum to exactly 100.</span></span></p> <h1><span style="font-size:16pt"><span style="font-family:"Times New Roman",serif"><span style="color:#2e74b5">🔍 Detailed review</span></span></span></h1> <h3><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><span style="color:#1f4d78">Team & execution</span></span></span></h3> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">The company reports a multidisciplinary team of Imperial College London / RCA founders plus specialist leads in engineering, agriculture and product, supported by advisors including Yulex founder Jeff Martin and a farming/wildlife advisor. Recognition includes Forbes 30 Under 30, the H&M Foundation Global Change Award and King Charles III's Terra Carta Design Lab. The platform materials explicitly flag execution risk across technical development, supply-chain build-out and market creation.</span></span></p> <table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:6.5in"> <thead> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:312px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">✅ Strengths</span></strong></span></span></p> </td> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:312px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">⚠️ Gaps</span></strong></span></span></p> </td> </tr> </thead> <tbody> <tr> <td style="border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:312px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Founding team from a strong Imperial/RCA engineering pedigree, corroborated on the public register.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Credible external validation: Forbes 30U30, Global Change Award, Terra Carta, BMW Foundation.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Relevant advisors (Yulex founder; farming/wildlife expertise).</span></span></li> </ul> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:312px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">No disclosed founder vesting or leaver provisions, so retention incentives are unclear.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Execution spans hard tech, agriculture and market creation simultaneously — explicitly flagged as high-risk.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">An investor-side individual (Counteract co-founder) sits among listed management — a related-party overlap.</span></span></li> </ul> </td> </tr> </tbody> </table> <h3><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><span style="color:#1f4d78">Product & technology (IP)</span></span></span></h3> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">BioPuff is a plant-based insulation from Typha grown via paludiculture, with wadding blended 80% Typha / 20% recycled polyester. The company reports thermal performance matching goose down at lower cost, and the deck cites a CLO value of 1.41 (100gsm wadding) versus 0.92 for PrimaLoft Gold, plus a favourable quote from an unnamed multinational outerwear brand. The processing technology is described as patent-pending.</span></span></p> <table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:6.5in"> <thead> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:312px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">✅ Strengths</span></strong></span></span></p> </td> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:312px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">⚠️ Risks</span></strong></span></span></p> </td> </tr> </thead> <tbody> <tr> <td style="border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:312px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Quantified performance edge in the deck (CLO 1.41 vs 0.92) and reported goose-down-equivalent warmth at lower cost.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Multi-product model (wadding, garments, merchandise, D2C) spreads sales-cycle risk.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Distinctive regeneration-linked supply chain that brands can market.</span></span></li> </ul> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:312px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">IP is only patent-pending; no granted-patent detail, and the platform flags that protections may be insufficient.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Key performance figures are company-provided and not independently audited in the materials.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">The '22 nonwovens' claim is attributed to an unnamed brand and cannot be verified.</span></span></li> </ul> </td> </tr> </tbody> </table> <h3><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><span style="color:#1f4d78">Traction & commercial validation</span></span></span></h3> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Ponda has provided material or prototypes to Berghaus, Stella McCartney (Falabella bag, AW24), Ahluwalia (AW26) and Sheep Inc., participates in Parley's Future Material initiative, and reports harvesting 12 tonnes of material in 2025, up from 3.5 tonnes in 2022. Brand use is independently corroborated by trade media. However, this engagement has not yet converted into meaningful revenue.</span></span></p> <table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:6.5in"> <thead> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:312px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">✅ Strengths</span></strong></span></span></p> </td> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:312px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">⚠️ Gaps</span></strong></span></span></p> </td> </tr> </thead> <tbody> <tr> <td style="border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:312px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Named brand partnerships independently corroborated (Berghaus, Stella McCartney, Ahluwalia, Sheep Inc.).</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Output scaling from 3.5t (2022) to 12t (2025) shows production progress.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Direct wadding sales and merchandise collaborations create multiple commercial entry points.</span></span></li> </ul> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:312px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Brand relationships are largely pilots/prototypes, not committed volume contracts.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">FY2025 turnover of c.£21k shows traction has not yet monetised.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Customer-concentration risk is flagged: dependence on a few key relationships.</span></span></li> </ul> </td> </tr> </tbody> </table> <h3><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><span style="color:#1f4d78">Market & competition</span></span></span></h3> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">The deck sizes the opportunity at TAM £10B (EU & UK insulation and non-wovens, premium outdoor apparel), SAM £800M, and SOM £25M (3% of SAM by 2030), citing EDANA, Grand View Research and others. The platform materials note competition from both incumbent synthetic fills and down, and from other emerging sustainable materials, and warn that textile adoption of new materials is slow.</span></span></p> <table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:6.5in"> <thead> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:312px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">✅ Advantages</span></strong></span></span></p> </td> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:312px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">⚠️ Threats</span></strong></span></span></p> </td> </tr> </thead> <tbody> <tr> <td style="border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:312px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Large addressable market with genuine regulatory and consumer pressure toward sustainable fills.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Positioned as a direct alternative to both down and petroleum-based synthetics.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Regeneration story differentiates against generic 'eco' materials.</span></span></li> </ul> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:312px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Market sizing is high-level; underlying figures are not itemised (LIMITED data quality).</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Incumbents and better-capitalised rivals may have lower costs and mature certifications.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Adoption cycles in apparel are long (testing, certification, internal approval).</span></span></li> </ul> </td> </tr> </tbody> </table> <h3><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><span style="color:#1f4d78">Financials & runway</span></span></span></h3> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Reported figures show turnover of £11,979 (FY2023), £20,759 (FY2024) and £20,890 (FY2025), against EBITDA of roughly -£651k, -£871k and -£790k respectively. The FY2025 net-debt figure is negative (a net cash position of c.£0.99m), consistent with the 2025 seed capital. The deck states runway to November 2027.</span></span></p> <table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:6.5in"> <thead> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:312px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">✅ Strengths</span></strong></span></span></p> </td> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:312px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">⚠️ Risks</span></strong></span></span></p> </td> </tr> </thead> <tbody> <tr> <td style="border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:312px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Funded runway stated through November 2027, giving time to reach commercial milestones.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Net cash position at FY2025 (c.£0.99m) after the seed round.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Losses are broadly stable rather than accelerating sharply.</span></span></li> </ul> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:312px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Revenue is negligible (c.£21k) and essentially flat year-on-year.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Sustained operating losses mean further raises will be needed, implying more dilution.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Micro-entity accounts provide limited financial transparency.</span></span></li> </ul> </td> </tr> </tbody> </table> <h3><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><span style="color:#1f4d78">Deal terms & investor protection</span></span></span></h3> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">The instrument is nominee-held Series Seed equity with pro rata voting. It carries a liquidation preference, but the surplus split directs 99.99999% to Ordinary / B Ordinary / Pro Rata Series Seed and only 0.00001% to Series Seed, effectively capping this round's upside. No valuation, ownership %, anti-dilution or pre-emption rights are disclosed, and the stake is illiquid with drag-along above 50%.</span></span></p> <table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:6.5in"> <thead> <tr> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:312px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">✅ Strengths</span></strong></span></span></p> </td> <td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:312px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">⚠️ Risks</span></strong></span></span></p> </td> </tr> </thead> <tbody> <tr> <td style="border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:312px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Tag-along rights let you join a change-of-control sale on the same terms.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">A liquidation preference gives Series Seed priority over Ordinary on return of capital.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Meaningful insider commitment this round (£392,979, 28.07% of target).</span></span></li> </ul> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:312px"> <ul> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Surplus split caps Series Seed upside on a strong exit — an adverse structure.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">No disclosed valuation or ownership %, so price fairness cannot be judged.</span></span></li> <li><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">No anti-dilution or pre-emption; drag-along at >50%; nominee-held and illiquid.</span></span></li> </ul> </td> </tr> </tbody> </table> <h1><span style="font-size:16pt"><span style="font-family:"Times New Roman",serif"><span style="color:#2e74b5">🚩 Red flags and integrity checks</span></span></span></h1> <table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:6.5in"> <tbody> <tr> <td style="background-color:#fcebeb; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:180px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Target-amount discrepancy</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:444px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">The binding KIIS target is £1,400,003, but Republic's pre-registration page and April/May 2026 press describe a minimum of only ~£200k / €230k "with no cap." These are not reconcilable as stated; the KIIS figure is treated as primary.</span></span></p> </td> </tr> <tr> <td style="background-color:#fcebeb; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:180px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Valuation opacity</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:444px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">No pre-money, post-money, equity % or valuation methodology is disclosed. A retail investor cannot compute ownership or judge price.</span></span></p> </td> </tr> <tr> <td style="background-color:#fcebeb; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:180px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Adverse surplus split</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:444px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Series Seed receives its preference first but only 0.00001% of the surplus, which caps upside on a high-value exit — unusual and adverse to this round's investors.</span></span></p> </td> </tr> <tr> <td style="background-color:#faece7; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:180px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Prior-round figures inconsistent</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:444px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">The deck says "£1.3m in 2025", Republic cites a "£1.8m VC seed", and press reports ~$2.4M; currency and rounding explain part but not all of the gap.</span></span></p> </td> </tr> <tr> <td style="background-color:#faece7; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:180px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Related-party in management</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:444px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Matthew Isaacs (listed management) is a co-founder/partner of Counteract, a co-lead of the prior seed round — an investor-side individual among management.</span></span></p> </td> </tr> <tr> <td style="background-color:#faece7; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:180px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Unaudited claims</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:444px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">CLO values, CO2e figures and biodiversity multipliers are company-provided; the platform states it does not audit business-supplied evidence.</span></span></p> </td> </tr> <tr> <td style="background-color:#d9ebc2; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:180px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">Integrity checks passed</span></strong></span></span></p> </td> <td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:444px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Company identity confirmed (SALTYCO LTD, 12614828) across KIIS, deck and Companies House; founders and brand partnerships corroborated by independent media; no same-named-company confusion found.</span></span></p> </td> </tr> </tbody> </table> <h1><span style="font-size:16pt"><span style="font-family:"Times New Roman",serif"><span style="color:#2e74b5">📋 Data quality notes</span></span></span></h1> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Overall data quality is MODERATE. Identity, team and traction are well-corroborated by the public register and independent trade media (STRONG). Product/technology, financials and deal terms are MODERATE — capped at 85 in scoring. Market sizing and the impact thesis rest on company-provided or secondary figures that are not independently itemised or audited (LIMITED — capped at 70). The principal gaps are the undisclosed valuation and cap table, the unreconciled target-amount discrepancy between the KIIS (£1.4m) and press (~£200k), and unaudited performance/impact metrics. Where the KIIS and press conflict, the KIIS/FICI figures are treated as primary.</span></span></p> <p> </p> <table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:6.5in"> <tbody> <tr> <td style="background-color:#e6f1fb; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:624px"> <p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><span style="color:black">Memo generated by AI from public information and platform-disclosed company materials. Investors must perform their own due diligence. Past fundraising or operational performance does not guarantee future results. Crowdfunding investments are illiquid, high-risk, and capital loss is possible.</span></span></span></p> </td> </tr> </tbody> </table> <p> </p>
See full overview
Ask question
Ask AI about this project
Beta
Démarrer une conversation
Envoyez un message pour commencer à discuter avec l'assistant IA
Like this project?
Platform offering this project
Seedrs GB
Risk Level
Élevé
Return Level
Très Élevé
Risk Return Level
Good
Investissement minimum
GBP 10
Financé
GBP 3392,59M
